Key terms
About TIL
Instil Bio, Inc. is a clinical-stage biopharmaceutical company engaged in developing a cell therapy pipeline of autologous tumor infiltrating lymphocyte therapies for the treatment of patients with cancer. The company was founded in August 2018 and is headquartered in Dallas, TX.
Sector
Industry
Employees
Founded
Website
Key stock statistics
1-day range
52-week range
Market cap
P/E ratio
Next earnings date
Dividend yield
Ex-dividend date
Dividend pay date
Key terms
Ad Feedback
Smart score
Latest TIL news
Apr 12
5:20am ET
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Instil Bio (TIL) and Regeneron (REGN)
Apr 12
5:00am ET
Instil Bio downgraded to Hold from Buy at Jefferies
Mar 25
6:20am ET
Wall Street Analysts Are Bullish on Top Healthcare Picks
Feb 14
4:26pm ET
Instil Bio Executives Secure Retention Bonus Agreements
Jan 22
3:30pm ET
Analysts’ Top Healthcare Picks: Instil Bio (TIL), Evolus (EOLS)
Jan 19
3:03am ET
Instil Bio Partners for ITIL-306 Preclinical Manufacturing Studies
No recent press releases are available for TIL
TIL Financials
Key terms
Ad Feedback
TIL Forecasts
analyst rating
- buy
- hold
- sell
1-year stock price forecast
TIL Competitors
$ Market cap
P/E ratio
$ Price
1d change
52-week range
